Harmony Biosciences Holdings, Inc.
$1.84B- Market cap
- $2.45B
- Debt
- +$163.66M
- Cash
- −$775.34M
Capital structure 94% equity / 6% debt · EV / Revenue 2.12x · EV / EBITDA 7.23x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
HRMY · price snapshotP/E 15.52x
$42.07Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at CMCSA's multiple
$13.2468.5% below market
2.71 HRMY Annual EPS×4.88x CMCSA P/E=$13.24
Market $42.07Implied $13.24
CMCSA · price snapshotP/E 4.88x
$26.33Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at HRMY's multiple
$83.67217.8% above market
5.39 CMCSA Annual EPS×15.52x HRMY P/E=$83.67
Market $26.33Implied $83.67